Researchers face unique challenges when developing therapies for solid tumors, including cell heterogeneity, drug resistance, and a complex tumor microenvironment. To design ideal CAR-T cells for treating solid tumors, scientists screen for novel targets and optimize their workflows with sophisticated instruments.
